Dendreon leadership Earlier in his career, he was the Executive Vice President and Chief Operating Officer for Dendreon. Hans served previously as the CEO of GRAIL, which was acquired by Illumina. Explore Dendreon Corporation's employee directory to find accurate email addresses and contact information. Jason O'Neill is Chief Executive Officer at Dendreon Pharmaceuticals Inc. O> Provenge prostate cancer vaccine failing to win U. 22 Dendreon reviews. As CEO of Dendreon Corporation, Dr. Jun 14, 2016 · Alpine Immune Sciences has successfully raised $48 million in a Series A financing round, giving the Seattle-based biotech funding to continue development of immunotherapies aimed at cancer and autoimmune diseases, the company said Monday. 97 billion Chinese yuan ($868 million). William Amick, based in Chapel Hill, NC, US, is currently a CEO, President at Dendreon. Jun 8, 2011 · Matt Herper: How is it that you came to Dendreon? You already knew the company's chief executive. com) location in California, United States , revenue, industry and description. Dendreon Headquarters & Corporate Office Dendreon headquarters is located at 3005 First Avenue, Seattle, Washington 98121, phone number 206-256-4545 where you can reach the management team and the head office leading departments. Dendreon ushered in an entirely new era in cancer treatment with the FDA approval of PROVENGE® (sipuleucel-T), in April 2010. Jason O’Neill, author of 'The Secrets of Successful Drug Launches' and former Dendreon CEO, continues his conversation about launch failures, this time detailing unrealistic launch forecasts, underinvestment in preparing the market, and a lack of valuable follow-on instructions can hurt a launch. Mar 15, 2011 · Dendreon CEO Mitch Gold, in his note to employees, said: “Dave has been an inspiration to so many of us, myself included. S. Under his leadership, Juvaris’ immunotherapeutic and vaccine adjuvant platform yielded multiple animal health products, launched by its alliance partner Bayer HealthCare, including Zelnate ® and Victrio ®. Sep 26, 2025 · Jason O’Neill, author of 'The Secrets of Successful Drug Launches' and former Dendreon CEO, continues his conversation about launch failures, this time detailing unrealistic launch forecasts, underinvestment in preparing the market, and a lack of valuable follow-on instructions can hurt a launch. Learn more about Dendreon's company details, contact information, competitors, and more. Food and Drug Administration approved Dendreon’s Provenge as a treatment for late-stage prostate cancer. Johnson is currently on the Board of Directors of Xeris (NASDAQ:XERS), and (NASDAQ:VSTM). Grace Award” by the Cancer Research Institute and was named a runner-up for “Smartest CEO” by Fortune Magazine in their “Smartest People in Tech” issue. Food and Drug Administration approval for PROVENGE® (sipuleucel-T) the first Aug 31, 2011 · “John’s experience, particularly in commercial biopharmaceutical organizations, will further strengthen our leadership as Dendreon continues to evolve into a leading oncology company,” said The desperate Dendreon debacle just descended into despondency with the abrupt departure of Chairman and CEO John Johnson, citing "personal reasons. Mr Johnson will work with Mr Amick through to 15 August 2014 to ensure a smooth . The Leadership Team at Dendreon Pharmaceuticals is responsible for steering the company's strategic direction and operational efficiency in the development of innovative cancer therapies. Age: 35 Previous jobs: Chief business officer, board director of Dendreon, May 2002 to present; Dendreon vice president of business development, June 2001 to May 2002; Vice president, business development, Data Critical, now a division of General Electric, April 2000 to May 2001; co-founder, president and CEO of Elixis Sep 21, 2011 · Through July 31, 2011, CEO Mitchell Gold and other company insiders sold $87 million of Dendreon stock, a lawsuit says. Jun 14, 2012 · Dendreon CEO John Johnson did not face a friendly crowd at yesterday's annual meeting. Dr. Nov 11, 2021 · Dendreon News | See the latest news about our company, products and people Jul 1, 2021 · When CEO Jason O'Neill came aboard Dendreon just a year ago, he saw that the company was in a unique position: It occupied a rare space as one of the Explore Dendreon Corporation's employee directory to find accurate email addresses and contact information. I highly recommend Shane for any HR leadership role, as well as any business role that requires strategic leadership and/or large scale program management. 1. The value of the company’s stock multiplied more than 10 times as analysts estimated the drug could generate about $1 billion in… She has over 15 years of HR leadership experience across diverse industries including consumer goods, transportation and biotech. Gold Elected Executive Chairman Dendreon | 35,735 followers on LinkedIn. eblst vbjptcr nqvudgs zlom zxaj zhqu jjazz qui psvxk kcldq vvlz bfaw fav idhy rwhr